 |
|
The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
Cheolsu Kim, Ho Sup Lee, Chang-Ki Min, Je Jung Lee, Kihyun Kim, Dok Hyun Yoon, Hyeon Seok Eom, Hyewon Lee, Won Sik Lee, Ho-Jin Shin, Ji Hyun Lee, Yong Park, Jae-Cheol Jo, Young Rok Do, Yeung-Chul Mun
Korean J Intern Med. 2015;30(5):675-683. Published online 2015 Aug 27 DOI: https://doi.org/10.3904/kjim.2015.30.5.675
|
|
Citations to this article as recorded by
 Dynamic Monitoring of Serum Ferritin As An Adverse Prognostic Biomarker in Patients with Multiple Myeloma
Yanqing Zhang, Jiaqi Pan, Xi Chen, Lianjie Wang, Liyan Chen, Yaoyao Tian, Wei Wang
Biomarkers in Medicine.2021; 15(16): 1541. CrossRef Recent advances in multiple myeloma: a Korean perspective
Junshik Hong, Jae Hoon Lee
The Korean Journal of Internal Medicine.2016; 31(5): 820. CrossRef
|